MBX Biosciences, Inc. (MBX) Q4 2024 Annual Earnings
MBX·Reported March 17, 2025·Before market open
Diluted EPS came in at $-0.47, beat the $-0.59 consensus by $0.12.
Diluted EPS
$-0.47beat by $0.12
Consensus: $-0.59
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about MBX Biosciences, Inc.'s Q4 2024 earnings report.
MBX Biosciences, Inc. (MBX) reported Q4 2024 earnings on March 17, 2025 before market open.
MBX Biosciences, Inc. reported diluted EPS of $-0.47 for Q4 2024.
EPS beat the consensus estimate of $-0.59 by $0.12.
You can read the 10-K periodic report (0000950170-25-039838) directly on SEC EDGAR. The filing index links above go to sec.gov.